Seo, H-J <br/><br/>
An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.  [electronic resource] 

 -  Pharmacopsychiatry  Sep 2013 
 - 221-6 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-0795 
<br/><br/><label>Standard No.: </label>10.1055/s-0033-1353171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents, Second-Generation--administration & dosage<br/>Bupropion--administration & dosage<br/>Delayed-Action Preparations--adverse effects<br/>Depressive Disorder, Major--diagnosis<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Psychiatric Status Rating Scales<br/>Single-Blind Method